Tebubio

🔬 Are you looking to advance your biomarker research? We understand the challenges researchers face—delivering high-quality results under tight timelines while navigating complex methodologies. That’s why our Contract Research Services (CRS) are designed to provide the scientific expertise and cutting-edge solutions you need to succeed in the fast-evolving field of biomarkers. To showcase the capabilities of our CRS, we’ve developed an application note that highlights how our services can support and accelerate your biomarker research projects. Here’s what you’ll discover: ✅ Biomarker Innovation: Learn how we implement state-of-the-art techniques to identify, validate, and quantify biomarkers with precision and reliability. ✅ Expert Insights: See how our team of highly qualified scientists collaborates to deliver tailored solutions for your specific biomarker challenges. ✅ Real-World Applications: Explore case examples where our CRS have enabled breakthrough biomarker discoveries across various therapeutic areas. 🔧 This application note is not just a resource; it’s a glimpse into how Tebubio partner with researchers like you to drive impactful biomarker discoveries. ✨ Download the application note now and explore how our CRS can help you achieve your biomarker research goals efficiently and effectively: https://lnkd.in/e-gjrtxj #Biomarker #Services #Laboratory #BiomarkerDiscovery #ScientificInnovation #ContractResearchServices [WeAreTebubio]

🌟 Advance Your Research with Premium Biospecimens 🌟 Are you looking for reliable, ethically sourced biospecimens to take your research further? Tebubio is offering an exclusive opportunity to save up to 50% on Cureline Baltic’s premium human biospecimens, trusted by researchers for over 20 years. Whether your focus is in oncology, immuno-oncology or neurology Cureline Baltic’s biobank has you covered with: ✅ Tumour tissues and plasma for cancer and immunotherapy research ✅ Neurological samples for Alzheimer’s and Parkinson’s studies ✅ Blood and bone marrow for haematological research Cureline Baltic’s biospecimens come with de-identified clinical data to support robust, reproducible results, ensuring your research leads to meaningful insights. 💡 Why wait? This limited-time promotion is your chance to accesshigh-quality biospecimens at a fraction of the cost. 🔗 Learn more to advance your research today: https://lnkd.in/egGQqivx #HBS #LifeSciences #Research #Oncology #Biospecimens #Cureline #ScientificBreakthroughs #Tebubio [WeAreTebubio]

🔬 𝗘𝗻𝗵𝗮𝗻𝗰𝗲 𝘁𝗵𝗲 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗮𝗻𝗱 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆 𝗼𝗳 𝘆𝗼𝘂𝗿 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 🔬 Are you striving to reduce the time, sample volume, and variability in your experiments? RayBiotech’s C-Series Arrays offer an advanced solution for measuring multiple cyopkine simultaneously, empowering your research into critical processes such as apoptosis, inflammation, and the immune response. 🟩 No training required—easy to use 🟩 High specificity & sensitivity 🟩 Compatible with any chemiluminescent system 🟩 Get results in just 1 day ⏳ One week remaining! Take advantage of 25% off RayBiotech's Cytokine Membrane-Based Arrays before the promotion ends on 31st October. Join the many researchers who rely on RayBiotech for robust and reproducible data. Don’t miss this exclusive opportunity! 👉 Click here to learn more and order now! #LifeSciences #BiologyResearch #RayBiotech #ScientificInnovation #Promotion #ELISAKits [WeAreTebubio]

🔬 𝗦𝗶𝗺𝗽𝗹𝗶𝗳𝘆 𝗬𝗼𝘂𝗿 𝗖𝗲𝗹𝗹 𝗗𝗲𝗮𝘁𝗵 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 𝘄𝗶𝘁𝗵 𝗖𝘂𝘁𝘁𝗶𝗻𝗴-𝗘𝗱𝗴𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 In the world of cellular biology, apoptosis research is critical—but often challenging. Understanding mechanisms of programmed cell death can unlock new pathways for therapeutic discoveries, from cancer treatment to regenerative medicine. Yet, traditional methods for apoptosis detection can be time-consuming and error-prone. At Tebubio, we're committed to equipping researchers with the most reliable tools to tackle these challenges. That’s why we’re excited to introduce the Annexin V Apoptosis Plate Assay Kit from our trusted partner, Dojindo Europe GmbH. 💡 This innovative kit is designed to streamline your workflow: ➡️ Detect apoptosis efficiently using high-sensitivity detection of Annexin V-binding events. ➡️ Perform analyses directly on a plate format, reducing experimental variability. ➡️ Benefit from easy-to-use protocols that save time without compromising on data accuracy. Whether you’re exploring apoptosis pathways or assessing drug-induced cytotoxicity, this kit empowers you to get reproducible, high-quality results quickly and easily. Learn more about how this tool can enhance your cell death studies👉 #CellBiology #Apoptosis #LifeScienceResearch #AnnexinV #Dojindo [WeAreTebubio]

🌟𝗣𝗼𝘄𝗲𝗿 𝗬𝗼𝘂𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘄𝗶𝘁𝗵 𝗛𝗶𝗴𝗵-𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗖𝘆𝘁𝗼𝗸𝗶𝗻𝗲𝘀  🌟 In cell and gene therapy, every choice matters. Cytokines are essential for fine-tuning immune responses, guiding stem cell differentiation, and driving breakthroughs in regenerative medicine. With rigorously tested cytokines from our partner Abbkine Scientific, you gain the consistency and precision your work demands. If your research is focused on immune modulation or advanced cellular therapies, Abbkine Scientific's cytokines are here to help elevate your results. Together, we’re supporting scientists on the path to innovative discoveries. 🔹 Now, enjoy a 13% discount on select cytokines: https://lnkd.in/epr2NUc9 #CellTherapy #GeneTherapy #CytokineResearch #BiotechInnovation #Immunotherapy #RegenerativeMedicine #LifeSciences [WeAreTebubio]

⏳ 𝗢𝗻𝗹𝘆 𝟮 𝗗𝗮𝘆𝘀 𝗟𝗲𝗳𝘁 𝘁𝗼 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿! 𝗝𝗼𝗶𝗻 𝗧𝗲𝗯𝘂𝗯𝗶𝗼’𝘀 𝗘𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 Are you looking to elevate your proteomic and biomarker research? This is your last chance to discover cutting-edge solutions tailored to your project’s needs. 📅 Date: 21st November, 11:00 AM CET ⏰ Duration: 45 minutes (live session + Q&A) Why Should You Attend? Discover how partnering with Tebubio can elevate your proteomic research through our biomarker and biostatistics expertise. ✅Explore our flexible solutions, ranging from ELISA to multiplexing over 8000 targets, tailored to any project stage. ✅Benefit from our comprehensive solutions and technical expertise spanning in vitro model development, target identification, and biostatistical analysis ✅Through two case studies, learn how we have supported researchers—from academic labs to pharmaceutical companies—in advancing their projects while optimising costs, timescales, and resources. 💡 Don’t miss out—this webinar is designed for researchers at academic labs and pharmaceutical companies who want to push their projects further. 🔗 Secure your spot now and take a step towards more precise research: https://lnkd.in/eNrbFWFk #Webinar #Tebubio #Biomarker #LifeSciences #Experts #Biostatistic [WeAreTebubio]

🌟 New Partnership: Certest Pharma Pharma Lipids & LNP Solutions Now Available at Tebubio! We’re thrilled to announce our new collaboration with Certest Pharma, further enhancing our Lipids & LNP formulation offering! Why it matters for you: ➡️ Exclusive access to Certest Pharma’s library of 1500+ lipids and 200+ LNP formulations, including extrahepatic lipids for targeted delivery beyond the liver. ➡️ Customised LNP solutions for mRNA/RNA therapeutics, vaccine research, and gene therapy. ➡️ Full access to Certest Pharma’s expertise through Tebubio CRS, allowing us to develop bespoke formulations tailored to your needs. This partnership enables us to continue offering innovative, tailored solutions, helping you advance your research with greater precision and efficiency. 🔗 Explore their 5 foundational lipids here to start building your targeted LNP solutions: https://lnkd.in/ez-tW9Zn #Tebubio #CERTEST #Lipids #LNP #TargetedDelivery #Innovation [WeAreTebubio]

🎯Stay at the Forefront of Immuno-Oncology with Our Latest Insights! The immuno-oncology field is booming, projected to grow 9-12% annually through 2030, driven by breakthroughs and new therapies. But key challenges, like immune evasion and limited patient eligibility, underscore the need for more inclusive, effective treatments. Here’s what you’ll find in Edition 2 of our journal: 🔬 𝗕𝗹𝗼𝗴 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗛𝗮𝗿𝗻𝗲𝘀𝘀𝗶𝗻𝗴 𝗺𝗥𝗡𝗔 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 Explore how modified NTPs enhance mRNA stability, pushing the boundaries of cancer vaccine research. These advancements could be game-changers in developing resilient, high-efficacy vaccines for immuno-oncology. 💡 𝗢𝘂𝘁𝘀𝗼𝘂𝗿𝗰𝗲 𝘄𝗶𝘁𝗵 𝗖𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲 𝗳𝗼𝗿 𝗖𝘂𝘀𝘁𝗼𝗺 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 Seeking tailored research solutions? Tebubio’s CRS helps accelerate your studies with specialised support for mRNA vaccines in preclinical applications, paving the way for the future of personalised cancer immunotherapy. ⚙️ 𝗧𝗼𝗽-𝗧𝗶𝗲𝗿 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀 & 𝗘𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝗥𝗲𝘀𝗼𝘂𝗿𝗰𝗲𝘀: Discover trusted products and essential resources to support your research needs, from stimulus solutions to model development and advanced analysis tools. We’ve partnered with top suppliers to ensure you have everything required to drive your immuno-oncology research forward. Explore the insights in our second edition here 👉: https://lnkd.in/eMbsW-E7 #ImmunoOncology #CancerResearch #Immunotherapy #ResearchSolutions #OncologyResearch [WeAreTebubio]

🔬🌍 𝗪𝗼𝗿𝗹𝗱 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗗𝗮𝘆: 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗳𝗼𝗿 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 🌍🔬   Today, on #WorldDiabetesDay, we’re highlighting the urgent need for transformative diabetes research as millions worldwide are impacted by this chronic disease. In our quest to improve outcomes, we are proud to distribute pancreatic islets from our partner PRODO LABORATORIES, INC., whose high-quality cells are essential for advancing cell-based diabetes therapies.   Pancreatic islets hold immense promise in the field of regenerative medicine. By replicating natural insulin production, these cells offer a potential pathway to insulin independence for patients with Type 1 diabetes. This innovative approach not only tackles the biological challenges of diabetes but also brings hope for personalised, cell-based therapies that could fundamentally change the way we address chronic conditions.   Our dedication at Tebubio to responsible innovation is closely aligned with supporting biological research partners like PRODO LABORATORIES, INC.. Together, we aim to push the boundaries of scientific discovery in diabetes treatment, focusing on solutions that are both life-changing for patients and sustainable for healthcare systems worldwide.   #DiabetesResearch #WorldDiabetesDay #PancreaticIslets #LifeSciences #Tebubio [WeAreTebubio]

🔬 𝗨𝗻𝗹𝗼𝗰𝗸 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗶𝗻 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 – 𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗪𝗲𝗯𝗶𝗻𝗮𝗿! 🚀 Don’t miss out! Reserve your place now for an exclusive webinar designed to enhance your biomarker and proteomic research journey with Tebubio. 📅 Date: 21st November, 11:00 am CET  ⏰ Duration: 45-minute live session & discussion Why Attend? ✨𝗚𝗮𝗶𝗻 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗘𝘅𝗽𝗲𝗿𝘁𝘀 Our team of scientists and biostatisticians will showcase how Tebubio’s bespoke biomarker solutions can streamline and strengthen your research, at any stage. 🔬 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂’𝗹𝗹 𝗟𝗲𝗮𝗿𝗻 - Integrate advanced biomarker solutions seamlessly with our Europe-based platform. - Access tailored support for any model, from in vitro to in vivo studies. - Explore flexible options, from ELISA to multiplexing over 8,000 targets. 💼 𝗠𝗲𝗲𝘁 𝘁𝗵𝗲 𝗘𝘅𝗽𝗲𝗿𝘁: 𝗗𝗿 𝗠𝗮𝗿𝗶𝗲 𝗠𝗼𝗿𝗶𝗻 Join Dr Marie Morin, PhD, Project Manager at Tebubio and specialist in Genomic and Transcriptomic analysis. Since joining in 2023, Dr Morin has been helping clients optimise their biomarker studies, from experimental design to statistical analysis. With the event fast approaching, secure your spot now to gain insights that could redefine your research approach. 🔗 Register today to unlock precision in your biomarker research: https://lnkd.in/eNrbFWFk #Webinar #Tebubio #Biomarker #LifeSciences #Experts #Biostatistic [WeAreTebubio]